SWOG clinical trial number
SWOG-7812

Evaluation of Anguidine (NSC-141537) in the Treatment of Central Nervous System Tumors

Closed
Abbreviated Title
Evaluation of Anguidine (NSC-141537) in the Treatment of Central Nervous System Tumors
Activated
06/21/1978
Closed
02/12/1980

Publication Information Expand/Collapse

1983

Phase II evaluation of Anguidine in central nervous system tumors. A Southwest Oncology Group study.

JW Goodwin;RH Bottomley;CB Vaughn;J Frank;RP Pugh Cancer Treat Rep 67:285-286

Anguidine (Diacetoxyscerpenol) in central nervous system tumors. A Southwest Oncology Group study.

W Goodwin;R Bottomley;C Vaughn;J Frank;R Pugh ASCO, #C-900